Finance

Beta
Lists
PEPG:NASDAQ
PepGen Inc
$1.77
-2.75%
(-0.050) 1D
$1.70
-3.95% (-0.070)
After hours
Closed: Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PEPG...
Open
$1.84
High
$1.85
Low
$1.74
Mkt. cap
122.08M
Avg. vol.
731.44K
Volume
529.37K
52-wk high
$7.80
52-wk low
$1.01
EPS
-$1.75
Beta
1.93
Shares outstanding
69.17M
No. of employees
59
Open
$1.84
High
$1.85
Low
$1.74
Mkt. cap
122.08M
Avg. vol.
731.44K
Volume
529.37K
52-wk high
$7.80
52-wk low
$1.01
EPS
-$1.75
Beta
1.93
Shares outstanding
69.17M
No. of employees
59
News stories
From sources across the web
About PepGen Inc
CEO-
Employees59
Founded2018
Headquarters-
SectorBiotechnology
Websitepepgen.com
Analyst Ratings
Based on 7 analysts giving stock ratings to PEPG in the past 3 months
Buy
Buy
6
Hold
0
Sell
1
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PEPG in the last 3 months.
Highest
Current $1.77
$20.00 (+1,029.94%)
Average
$10.29 (+481.36%)
Lowest
$3.00 (+69.49%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Adam Vogel
Craig-Hallum
Buy
Initiated
$11.00
+521.5%
06/16/2026
Ananda Ghosh
H.C. Wainwright
Buy
Reiterated
$20.00
+1,029.9%
05/29/2026
Tazeen Ahmad
Bank of America Securities
Sell
Reiterated
$3.00
+69.5%
05/21/2026
Laura Chico
Wedbush
Buy
Maintained
$4.00
+126%
05/13/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$12.00
+578%
04/04/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
$7.00
+295.5%
03/31/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$15.00
+747.5%
03/31/2026
Unknown Analyst
Wedbush
Buy
Maintained
$9.00
+408.5%
03/23/2026
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.26 / -$0.31
+16.80%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
18.39M
13.42M
13.85M
13.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.54M
5.23M
5.85M
5.94M
Operating expense
23.93M
18.65M
19.70M
18.94M
Total operating expenses
23.93M
18.65M
19.70M
18.94M
Operating income
-23.93M
-18.65M
-19.70M
-18.94M
Other non operating income
3.00K
-6.00K
-5.00K
-56.00K
EBT including unusual items
-23.09M
-18.03M
-18.29M
-17.75M
EBT excluding unusual items
-23.09M
-18.03M
-18.29M
-17.75M
Income tax expense
-
-
49.00K
15.00K
Effective tax rate
-
-
-0.27%
-0.08%
Other operating expenses
-
-
-
-
Net income
-23.09M
-18.03M
-18.34M
-17.76M
Net profit margin
-
-
-
-
Earnings per share
-0.70
-0.52
-0.27
-0.26
Interest and investment income
842.00K
634.00K
1.42M
1.25M
Interest expense
-
-
-
-
Net interest expenses
842.00K
634.00K
1.42M
1.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.60M
-18.32M
-19.37M
-18.62M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer